Published

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics
Date: 2021-01-01
Source: PubMed
DOI: 10.1007/s13311-020-00962-y
PubMed: 33184743

Authors

Schindler EAD Sewell RA Gottschalk CH Luddy C Flynn LT Lindsey H Pittman BP Cozzi NV D'Souza DC

Watch author

Derived topics and classifications

psilocybin Headache / Migraine Receptor Pharmacology Safety Adverse Events Other

Citation graph

0 referenced DOIs found in stored source metadata. 5 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia2026-04-24 Pilot study of psilocybin in patients with post-treatment lyme disease2026-02-25 Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress2026-01-02 Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects2022-12-01 Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.2021-01-01

Related papers

Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.Headache · 2026-04-01 Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.Headache · 2024-01-01 Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.Headache · 2022-11-01 Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01 Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging StudyClinicalTrials.gov · 2022-08-10 Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.The journal of headache and pain · 2025-05-23 Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-09